Vitamin D and Hereditary Haemorrhagic Telangiectasia
Status:
Unknown status
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
The study aims to assess whether supplementing vitamin D in patients diagnosed with
Hereditary Haemorrhagic Telangiectasia (HHT) will decrease the frequency and severity of
nosebleeds these patients experience. It is hypothesized that the larger the dose of daily
vitamin D given to the patients, the less frequent and less severe the nosebleeds will be.